BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22693231)

  • 1. Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection.
    Villacres MC; Kono N; Mack WJ; Nowicki MJ; Anastos K; Augenbraun M; Liu C; Landay A; Greenblatt RM; Gange SJ; Levine AM
    J Infect Dis; 2012 Sep; 206(5):780-9. PubMed ID: 22693231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Key Elements in the Innate Immunity System Among Patients with HIV, HCV, and Coinfections of HIV/HCV.
    Moradi M; Tabibzadeh A; Javanmard D; Ghorbani S; Bokharaei-Salim F; Keivani H; Khazeni M; Monavari SHR
    Curr HIV Res; 2020; 18(3):194-200. PubMed ID: 32209045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
    Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
    J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
    J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.
    MacParland SA; Fadel SM; Mihajlovic V; Fawaz A; Kim C; Rahman AK; Liu J; Kaul R; Kovacs C; Grebely J; Dore GJ; Wong DK; Ostrowski MA
    PLoS One; 2016; 11(4):e0154433. PubMed ID: 27124305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.
    Kerzerho J; McIlvaine EJ; Anthony P; Mack WJ; Wang CH; Frederick T; Operskalski E; Chen Z; Al-Harthi L; Landay A; Young MA; Tien PC; Augenbraun M; Strickler HD; Akbari O; Golub ET; Sharp GB; Kovacs A
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):172-80. PubMed ID: 26761519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of hepatitis C virus coinfection on immune restoration during successful antiretroviral therapy in chronic human immunodeficiency virus type 1 disease.
    Santin M; Mestre M; Shaw E; Barbera MJ; Casanova A; Niubo J; Bolao F; Podzamczer D; Gudiol F
    Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):65-73. PubMed ID: 17938979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of hepatitis C virus in HIV coinfected patients under antiretroviral therapy.
    Sede M; Parra M; Manrique JM; Laufer N; Jones LR; Quarleri J
    Infect Genet Evol; 2016 Sep; 43():186-96. PubMed ID: 27234841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection.
    Fan Z; Huang XL; Kalinski P; Young S; Rinaldo CR
    Clin Vaccine Immunol; 2007 Sep; 14(9):1127-37. PubMed ID: 17634507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hepatitis C virus coinfection on CD4⁺ T cells of HIV-infected patients receiving HAART.
    Shmagel KV; Saidakova EV; Korolevskaya LB; Shmagel NG; Chereshnev VA; Anthony DD; Lederman MM
    AIDS; 2014 Oct; 28(16):2381-8. PubMed ID: 25111083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract.
    Nkwanyana NN; Gumbi PP; Roberts L; Denny L; Hanekom W; Soares A; Allan B; Williamson AL; Coetzee D; Olivier AJ; Burgers WA; Passmore JA
    Immunology; 2009 Sep; 128(1 Suppl):e746-57. PubMed ID: 19740336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.
    Hodowanec AC; Brady KE; Gao W; Kincaid SL; Plants J; Bahk M; Landay AL; Huhn GD
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):232-40. PubMed ID: 24131865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy.
    Piconi S; Trabattoni D; Gori A; Parisotto S; Magni C; Meraviglia P; Bandera A; Capetti A; Rizzardini G; Clerici M
    AIDS; 2010 Aug; 24(13):1991-2000. PubMed ID: 20651586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C coinfection enhances sensitization of CD4(+) T-cells towards Fas-induced apoptosis in viraemic and HAART-controlled HIV-1-positive patients.
    Körner C; Tolksdorf F; Riesner K; Krämer B; Schulte D; Nattermann J; Rockstroh JK; Spengler U
    Antivir Ther; 2011; 16(7):1047-55. PubMed ID: 22024520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease.
    Shive CL; Mudd JC; Funderburg NT; Sieg SF; Kyi B; Bazdar DA; Mangioni D; Gori A; Jacobson JM; Brooks AD; Hardacre J; Ammori J; Estes JD; Schacker TW; Rodriguez B; Lederman MM
    J Infect Dis; 2014 Aug; 210(4):619-29. PubMed ID: 24585897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patients.
    Shen T; Chen X; Zhang W; Xi Y; Cao G; Zhi Y; Wang S; Xu C; Wei L; Lu F; Zhuang H
    PLoS One; 2011; 6(8):e23550. PubMed ID: 21858166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy.
    Castagna A; Galli L; Torti C; D'Arminio Monforte A; Mussini C; Antinori A; Cozzi-Lepri A; Ladisa N; De Luca A; Seminari E; Gianotti N; Lazzarin A
    Antivir Ther; 2010; 15(2):165-75. PubMed ID: 20386071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors.
    Sajadi MM; Pulijala R; Redfield RR; Talwani R
    AIDS; 2012 Sep; 26(15):1879-84. PubMed ID: 22824629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.
    Potter M; Odueyungbo A; Yang H; Saeed S; Klein MB;
    AIDS; 2010 Jul; 24(12):1857-65. PubMed ID: 20479633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.